Study Highlights Role of Protein Complexes in Epigenetic Drug Interactions
January 24, 2011
Study Highlights Role of Protein Complexes in Epigenetic Drug Interactions
Cellzome researchers from Germany and the UK used a chemoproteomic approach to look at protein complexes associated with several histone deacetylase inhibitors.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Cellzome Gets UK Grant for Stem Cell Tools Project
December 6, 2011 / GenomeWeb Daily News - Cellzome Hits Two Milestones in GSK Kinase Research Pact
September 16, 2011 / ProteoMonitor - Cellzome Teaming with Pfizer to Investigate the Epigenetics of Stem Cell Regulation
May 13, 2011 / ProteoMonitor - Cellzome Hits Second Milestone in GSK Epigenetics Collaboration
February 11, 2011 / ProteoMonitor - Cellzome Study Suggests Epigenetic Inhibitors' Efficacy Depends on Protein-Complex Interactions
January 28, 2011 / ProteoMonitor